| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Marker Therapeutics, Inc. | Chief Financial Officer | Common Stock | 114,436 | $55,479 | $0.4848 | 24 Mar 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MRKR | Marker Therapeutics, Inc. | 24 Mar 2022 | 2 | -$17,490 | 4 | Chief Financial Officer | 28 Mar 2022, 21:03 |
| MRKR | Marker Therapeutics, Inc. | 17 Feb 2022 | 1 | $0 | 4 | Chief Financial Officer | 22 Feb 2022, 16:06 |